S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.
about
From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical ResearchIdentification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQProteomic analysis of urinary upper gastrointestinal cancer markers.MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.Evaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation.Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.Increased expression of S100A6 promotes cell proliferation in gastric cancer cells.Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study.Distinct prognostic values of S100 mRNA expression in breast cancer.S100 protein family in human cancer.Epigenetic mechanisms in gastric cancer.Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.Molecular characterization of the porcine S100A6 gene and analysis of its expression in pigs infected with highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV).Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.S100A11 is a migration-related protein in laryngeal squamous cell carcinoma.S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 SignalingEpigenetic regulation of S100 protein expression.High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.S100 Proteins As an Important Regulator of Macrophage Inflammation.The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence.Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer.Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.PTK7 as a novel marker for favorable gastric cancer patient survival
P2860
Q28393309-8BFCC369-A9B4-4A24-B5F4-3269B5DD16F6Q28743151-9A60A0EC-34EE-4F6C-BC0F-E0147C3F7A33Q33888474-C0198BD1-07DF-4B00-AF53-8E27DB90D7AFQ34052933-20716A6D-8CA8-4C85-9D3F-6A3D2FAF5FF5Q34287040-CF261396-EF89-401E-9EB0-A521E488039EQ34668730-489C7804-1F2D-4F43-A264-8B434E0FD479Q35337546-1126C45F-AD99-4C93-AA2C-8D9D09B0ED1FQ36213122-8D1CB1BD-B000-41E4-B53E-94B2260523B6Q36260562-7AEB5346-12CC-49D7-9E3F-9A118E899FF6Q36964902-A771F230-A1EF-448C-B112-9921AB860EF3Q37554595-84754AAA-0DDA-4718-9234-92BFB297FE6AQ37650123-04A39ADB-4A64-4538-A342-C6AFEEB3B34CQ38018086-AFF8C8BF-B51E-4C80-AF3E-304BC385D2BDQ38703693-47721087-2EBB-4932-9A13-38E4CC983410Q38748164-AE568FDE-EFEA-4B9B-AE1C-C92AEE44FE6BQ38931788-AC23B901-F970-45A9-AA22-59CFE7350129Q38949202-73AC242A-E324-4310-912B-194927B74E84Q38966417-F187C9E1-AF2A-4C2B-ABD1-8718FB522EEBQ39007287-7D37772C-056A-432F-9E38-64B8316DD266Q39094418-28379D3F-EF48-48B0-80E8-A843DEEDA90AQ40958940-CB9925B9-C1C9-403F-ACBE-E9B5D2476E8DQ41810264-39F7DA11-4521-4C03-987E-64A2A3F24B2FQ44892815-51DA898F-BB41-4C49-9330-55E37D77A48FQ47912411-A97E6981-68D7-492A-9C08-88C3D8CD778AQ49497885-D18AFBAD-DA09-4964-BFEC-7E4A39F92362Q50551664-3EFB0000-4304-405C-93D0-67BD7BE4A7ADQ51769275-73CBD7C1-5E40-4EE1-B69D-23717CE1A27DQ52970611-97CEB7E1-B750-4CA0-81FD-210DB533C707Q53081345-9F68BDF2-C51D-4543-9291-EFFE44F254ABQ54120638-995ADABC-B92F-44A9-A6D4-7F4442E867C0Q54342844-C5879271-20CE-407D-9B14-3443FBB57060Q57280332-554C78F1-5EB5-490A-9335-08D8A3462BC5
P2860
S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@ast
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@en
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@nl
type
label
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@ast
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@en
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@nl
prefLabel
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@ast
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@en
S100A6 overexpression is assoc ...... p-regulated in gastric cancer.
@nl
P2093
P2860
P1476
S100A6 overexpression is assoc ...... up-regulated in gastric cancer
@en
P2093
Ai-Ping Lu
Gui-Guo Zhang
Lian-Hai Zhang
Shao-Hua Ge
Xi-Yao Zhong
Xiao-Fang Xing
P2860
P304
P356
10.2353/AJPATH.2010.091217
P407
P50
P577
2010-06-25T00:00:00Z